Critical evaluation of evidence: a lesson to learn from a recent meta‐analysis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Acta Obstetricia et Gynecologica Scandinavica

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00016340500430394PMID 16553171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin receptor antagonists for inhibiting preterm labour.

  2014cited by this paper
• Oxytocin receptor antagonists for inhibiting preterm labour.

  2008cited by this paper
• [Acute myocardial infarction during pregnancy].

  2007cited by this paper
• Severe hypotension and fetal death due to tocolysis with nifedipine

  2005cited by this paper
• Severe hypotension and fetal death due to tocolysis with nifedipine

  2005cited by this paper
• Severe hypotension and fetal death due to tocolysis with nifedipine

  2005cited by this paper
• Acute pulmonary oedema during nicardipine therapy for premature labour; Report of five cases.

  2004cited by this paper
• Pulmonary edema induced by calcium-channel blockade for tocolysis.

  2004cited by this paper
• Maternal hypoxia associated with nifedipine for threatened preterm labour

  2004cited by this paper
• Acute myocardial infarction during pregnancy

  2004cited by this paper
• Effectiveness and safety of the oxytocin antagonist atosiban versus beta‐adrenergic agonists in the treatment of preterm labour

  2003cited by this paper
• Effectiveness and safety of the oxytocin antagonist atosiban versus beta‐adrenergic agonists in the treatment of preterm labour

  2001cited by this paper
• Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

  2001cited by this paper
• The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.

  2001cited by this paper
• Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.

  2000cited by this paper
• An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.

  2000cited by this paper
• Myocardial infarction during nifedipine therapy for preterm labor.

  1999cited by this paper
• Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

  1996cited by this paper
• Dose Ranging Study of the Oxytocin Antagonist Atosiban in the Treatment of Preterm Labor

  1996cited by this paper
• The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

  1994influential reference

• Oxytocin receptor antagonists for inhibiting preterm labour.

  2008cites this paper
• The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban

  2007cites this paper
• Increased postpartum blood loss in pregnancies associated with placental malaria

  2007cites this paper